Interphase cytogenetics of workers exposed to benzene

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 6, 1996, Pages 1325-1329

  Zhang, Luoping ^a   Rothman, Nathaniel ^b   Wang, Yunxia ^a   Hayes, Richard B ^b   Bechtold, William ^c   Venkatesh, Pravina ^a   Yin, Songnian ^d   Wang, Yaozhu ^e   Dosemeci, Mustafa ^b   Li, Guilan ^d   Lu, Wei ^e   Smith, Martyn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Inhalation Toxicology Research Institutew   (United States)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e Shanghai Hygiene and Anti Epidemic Center   (China)

Author keywords

Aneuploidy; Benzene; Chromosome aberrations; Hyperdiploidy; Leukemia

Indexed keywords

1,2,4 BENZENETRIOL; BENZENE; HYDROQUINONE; PHENOL;

ANEUPLOIDY; BLOOD TOXICITY; CELL CULTURE; CHINA; CHROMOSOME 7; CHROMOSOME 9; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOGENETICS; DOSE RESPONSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTERPHASE; LYMPHOCYTE COUNT; MALE; NUMERICAL CHROMOSOME ABERRATION; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TRISOMY; URINE LEVEL;

EID: 12644275403     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.961041325     Document Type: Conference Paper

References (35)

1. Aksoy M. Benzene carcinogenicity. In: Benzene Carcinogenicity (Aksoy M, ed). Boca Raton, FL:CRC Press, 1988;113-151.
2. IARC. Benzene (Group 1). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 42, Suppl 7. Lyon:International Agency for Research on Cancer, 1987;120-122.
3. Dean BJ. Recent findings on the genetic toxicology of benzene, toluene, xylenes and phenols. Mutat Res 154:153-181 (1985).
4. Reddy MV, Schultz SC, Blackburn GR, Mackerer CR. Lack of DNA adduct formation in mice treated with benzene. Mutat Res 325:149-155 (1994).
5. Waters MD, Stack HF, Bradv AL, Lohman PH, Haroun L, Vainio H. Use of computerized data listings and activity profiles of genetic and related effects in the review of 195 compounds. Mutat Res 205:295-312 (1988).
6. Rothman N, Haas R, Hayes RB, Li GL, Wiemels J, Campleman S, Quintana PJ, Xi LJ, Dosemeci M, Titenko-Holland N, Meyer KB, Lu W, Zhang L, Bechtold W, Wang YZ, Kolachana P, Yin SN, Blot W, Smith MT. Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin A locus in exposed humans. Proc Natl Acad Sci USA 92:4069-73 (1995).
7. Major J, Jakab M, Kiss G, Tompa A. Chromosome aberration, sister-chromatid exchange, proliferative rate index, and serum thiocyanate concentration in smokers exposed to low-dose benzene. Environ Mol Mutagen 23:137-42 (1994).
8. Sasiadek M, Jagielski J. Genotoxic effects observed in workers occupationally exposed to organic solvents. Pol J Occup Med 3:103-108 (1990).
9. Tompa A, Major J, Jakab MG. Monitoring of benzene-exposed workers for genotoxic effects of benzene: improved-working-condition-related decrease in the frequencies of chromosomal aberrations in peripheral blood lymphocytes. Mutat Res 304:159-165 (1994).
10. Turkel B, Egeli U. Analysis of chromosomal aberrations in shoe workers exposed long term to benzene. Occup Environ Med 51:50-53 (1994).
11. Sasiadek M. Nonrandom distribution of breakpoints in the karyotypes of workers occupationally exposed to benzene. Environ Health Perspect 97:255-257 (1992).
12. Forni A, Moreo L. Cytogenetic studies in a case of benzene leukaemia. Eur J Cancer 3:251-255 (1967).
13. Forni A. Chromosome changes and benzene exposure. A review. Rev Environ Health 3:5-17 (1979).
14. Erdogan G, Aksoy M. Cytogenetic studies in thirteen patients with pancytopenia and leukaemia associated with long-term exposure to benzene. N Istanbul Contrib Clin Sci 10:230-247 (1973).
15. Aksoy M, Erdem S, Erdogan G, Dincol G. Acute leukaemia in two generations following chronic exposure to benzene. Hum Hered 24:70-74 (1974).
16. Sellyei M, Keleman E. Chromosome study in a case of granulocytic leukaemia with 'Pelgerisation' 7 years after benzene pancytopenia. Eur J Cancer 7:83-85 (1971).
17. Erdogan G, Aksoy M. Cytogenetic studies in 20 patients with pancytopenia and leukaemia with long-term exposure to benzene. In: European and African Division International Society of Hematology, 3rd Meeting, 24-28 August 1975, London.
18. Rowley JD, Blaisdell RK, Jacobson LO. Chromosome studies in preleukemia. I. Aneuploidy of group C chromosomes in three patients. Blood 27(6):782-799 (1966).
19. Winkelstein A, Sparkes RS, Craddock CG. Trisomy of group C in a myeloproliferative disorder. Report of case. Blood 27:722-33 (1966).
20. Sandberg AA, Ishihara T, Crosswhite LH. Group C-trisomy in myeloid metaplasia with possible leukaemia. Blood 24:716-25 (1964).
21. Gray JW, Pinkel D. Molecular cytogenetics in human cancer diagnosis. Cancer 69:1536-1542 (1992).
22. Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, Gray J. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Nacl Acad Sci USA 85:9138-9142 (1988).
23. Willard H, Waye J. Hierarchial order in chromosome specific human alpha satellite DNA. Trend Genet 3:192-198 (1987).
24. Zhang L, Venkatesh P, Creek ML, Smith MT. Detection of 1,2,4-benzenetriol induced aneuploidy and microtubule disruption by fluorescence in situ hybridization and immunocytochemistry. Mutat Res 320:315-327 (1994).
25. Eastmond DA, Rupa DS, Hasegawa LS. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite nydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat Res 322:9-20 (1994).
26. Rothman N, Li G-L, Dosemeci M, Bechtold W, Marti GE, Wang Y-Z, Linet M, Xi L-Q, Lu W, Smith MT, Titenko-Holland N, Zhang L, Blot W, Yin S, Hayes R. Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med 29:236-246 (1996).
27. Bechtold WE, Willis JK, Sun JD, Griffith WC, Reddy TV. Biological markers of exposure to benzene: S-phenylcysteine in albumin. Carcinogenesis 13:1217-1220 (1992).
28. Eastmond DA, Pinkel D. Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hydridization with chromosome-specific DNA probes. Mutat Res 234:303-318 (1990).
29. Yardley-Jones A, Anderson D, Parke DV. The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. Br J Ind Med 48:437-444 (1991).
30. Zhang L, Robertson ML, Kolachana P, Davison AJ, Smith MT. Benzene metabolite, 1,2,4-benzenetriol, induces micronuclei and oxidative DNA damage in human lymphocytes and HL60 cells. Environ Mol Mutagen 21:339-348 (1993).
31. Yager JW, Eastmond DA, Robertson ML, Paradisin WM, Smith MT. Characterization of micronuclei induced in human lymphocytes by benzene metabolites. Cancer Res 50:393-399 (1990).
32. Irons RD, Neptune DA. Effects of the prinicipal hydroxymetabolites of benzene on microtubule polymerization. Arch Toxicol 45:297-305 (1980).
33. Irons RD, Pfeifer RW, Aune TM, Pierce CW. Soluble immune response suppressor (SIRS) inhibits microtubule function in vivo and microtubule assembly in vitro. J Immunol 133:2032-2036 (1984).
34. Hagmar L, Brogger A, Hansteen IL, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa S, Skerfving S, Sorsa M. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:2919-2922 (1994).
35. Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P, Sbrana I, Vecchio D, Puntoni R. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79:133-135 (1995).